Low FEV1, smoking history, and obesity are factors associated with oxygen saturation decrease in an adult population cohort

International Journal of COPD

Volumn 9, Issue , 2014, Pages 1225-1233

  Vold, Monica Linea ^a,c   Aasebø, Ulf ^b   Melbye, Hasse ^c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b Department of Clinical Medicine ^*  (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Cohort study; General population; Lung function; Pulse oximetry

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER; OXYGEN;

ADULT; AGED; ARTICLE; ASTHMA; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PREDICTION; PULSE OXIMETRY; SMOKING; SOCIAL ASPECT; BLOOD; DISEASE COURSE; LUNG; MULTIVARIATE ANALYSIS; NORWAY; OXIMETRY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RISK; RISK FACTOR; SMOKING CESSATION; SPIROMETRY; STATISTICAL MODEL; TIME; WEIGHT REDUCTION;

AGED; ASTHMA; BIOLOGICAL MARKERS; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; LUNG; MALE; MULTIVARIATE ANALYSIS; NORWAY; OBESITY; ODDS RATIO; OXIMETRY; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SMOKING; SMOKING CESSATION; SPIROMETRY; TIME FACTORS; WEIGHT LOSS;

EID: 84908360654     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S69438     Document Type: Article

References (39)

1. Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis. 2011;6:199–208.
2. West JB. Causes of and compensations for hypoxemia and hypercapnia. Compr Physiol. 2011;1(3):1541–1553.
3. Young IH, Bye PT. Gas exchange in disease: asthma, chronic obstructive pulmonary disease, cystic fibrosis, and interstitial lung disease. Compr Physiol. 2011;1(2):663–697.
4. Crapo RO, Jensen RL, Hegewald MATH, Taskin DP. Arterial blood gas reference values for sea level and an altitude of 1,400 meters. Am J Respir Crit Care Med. 1999;160(5):1525–1531.
5. Little SA, Elkholy MM, Chalmers GW, Farouk A, Patel KR, Thomson NC. Predictors of nocturnal oxygen desaturation in patients with COPD. Respir Med. 1999;93(3):202–207.
6. Knower MT, Dunagan DP, Adair NE, Chin R Jr. Baseline oxygen saturation predicts exercise desaturation below prescription threshold in patients with chronic obstructive pulmonary disease. Arch Intern Med. 2001;161(5):732–736.
7. Edvardsen A, Akero A, Christensen CC, Ryg M, Skjonsberg OH. Air travel and chronic obstructive pulmonary disease: a new algorithm for pre-flight evaluation. Thorax. 2012;67(11):964–969.
8. Canet J, Gallart L, Gomar C, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113(6):1338–1350.
9. Roberts CM, Bugler JR, Melchor R, Hetzel MR, Spiro SG. Value of pulse oximetry in screening for long-term oxygen therapy requirement. Eur Respir J. 1993;6(4):559–562.
10. Vold ML, Aasebø U, Hjalmarsen A, Melbye H. Predictors of oxygen saturation #95% in a cross-sectional population based survey. Respir Med. 2012;106(11):1551–1558.
11. Ahmadi-Abhari S, Kaptoge S, Luben RN, Wareham NJ, Khaw KT. Longitudinal association of C-reactive protein and lung function over 13 years: The EPIC-Norfolk study. Am J Epidemiol. 2014;179(1): 48–56.
12. Kalhan R, Tran BT, Colangelo LA, et al. Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS One. 2010;5(7):e11431.
13. Rosenberg SR, Kalhan R. Biomarkers in chronic obstructive pulmonary disease. Transl Res. 2012;159(4):228–237.
14. Agusti A, Soriano JB. COPD as a systemic disease. COPD. 2008;5(2):133–138.
15. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
16. Kapsimalis F, Varouchakis G, Manousaki A, et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung. 2008;186(4):209–217.
17. Roche F, Gaspoz JM, Pichot V, et al. Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly. Eur Respir J. 2009;33(4):797–803.
18. Vijayan VK. Morbidities associated with obstructive sleep apnea. Expert Rev Respir Med. 2012;6(5):557–566.
19. Aksu F, Capan N, Aksu K, et al. C-reactive protein levels are raised in stable chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013;5(4):414–421.
20. de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006;27(5):902–907.
21. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njolstad I. Cohort profile: the Tromso Study. Int J Epidemiol. 2011;41(4):961–967.
22. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338.
23. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trondelag Study. Eur Respir J. 2001;18(5):770–779.
24. Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Manninio DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180(1):3–10.
25. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645–1648.
26. Kunzli N, Kuna-Dibbert B, Keidel D, et al. Longitudinal validity of spirometers – a challenge in longitudinal studies. Swiss Med Wkly. 2005;135(33–34):503–508.
27. Szklo M, Nieto FJ. Epidemiology: Beyond the Basics. 2nd ed. Massachusetts: Jones and Bartlett Publishers; 2007.
28. Tirlapur VG, Gicheru K, Charalambous BM, Evans PJ, Mir MA. Packed cell volume, haemoglobin, and oxygen saturation changes in healthy smokers and non-smokers. Thorax. 1983;38(10):785–787.
29. Ouattara S, Keita M, Tuo N, Dah C, Siransy EA, Bogui P. Effect of smoking on PaO2 at rest and during moderate exercise. Dakar Med. 2002;47(1):90–95.
30. Casanova C, de Torres JP, Navarro J, et al. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(8):1004–1010.
31. Komurcuoglu A, Kalenci S, Kalenci D, Komurcuoglu B, Tibet G. Microalbuminuria in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 2003;59(4):269–272.
32. Laaban JP, Cassuto D, Orvoen-Frija E, et al. Cardiorespiratory consequences of sleep apnoea syndrome in patients with massive obesity. Eur Respir J. 1998;11(1):20–27.
33. Verin E, Tardif C, Pasquis P. Prevalence of daytime hypercapnia or hypoxia in patients with OSAS and normal lung function. Respir Med. 2001;95(8):693–696.
34. Zavorsky GS, Hoffman SL. Pulmonary gas exchange in the morbidly obese. Obes Rev. 2008;9(4):326–339.
35. Melbye H, Joensen L, Risor MB, Halvorsen PA. Symptoms of respiratory tract infection and associated care-seeking in subjects with and without obstructive lung disease; the Tromso Study: Tromso 6. BMC Pulm Med. 2012;12:51.
36. Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–1093.
37. Vartiainen E, Seppala T, Lillsunde P, Puska P. Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health. 2002;56(3):167–170.
38. Jensen LA, Onyskiw JE, Prasad NG. Meta-analysis of arterial oxygen saturation monitoring by pulse oximetry in adults. Heart Lung. 1998;27(6):387–408.
39. Quanjer PH, Hall GL, Stanojevic S, Cole TJ, Stocks J. Age-and height-based prediction bias in spirometry reference equations. Eur Respir J. 2012;40(1):190–197.